Nasus Pharma Ltd (NSRX) Operating cash flow 2023–2025
Nasus Pharma Ltd (NSRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.9MFY2025 · since FY2023: -$1.0M → -$4.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.9M | -639.5% |
| FY2024 | -$665,000 | +35.4% |
| FY2023 | -$1.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice